PETS
PetMed Express Inc
1.60$
-1.2%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 94.7% | 97.0% | 74.9% | 72.5% | 78.0% | 81.9% | 83.1% | 86.0% | 85.6% | 76.7% | 55.1% | 53.7% | |
| 23.4% | 43.0% | 41.7% | 52.1% | 57.8% | 65.1% | 66.8% | 63.3% | 63.0% | 61.2% | 32.5% | 26.4% | |
| 43.2% | 61.8% | 41.7% | 52.1% | 57.8% | 65.1% | 66.8% | 63.3% | 63.0% | 61.2% | 32.5% | 26.4% | |
| 2.2% | 2.3% | 1.9% | 1.6% | 1.7% | 1.6% | 2.5% | 1.4% | 1.1% | 1.0% | 1.9% | 2.4% | |
| 45.6% | 30.3% | 28.3% | 17.9% | 17.3% | 13.8% | 11.5% | 18.4% | 18.4% | 11.2% | 16.8% | 16.8% | |
| 1.7% | 1.9% | 23.2% | 26.7% | 21.3% | 17.6% | 16.4% | 13.6% | 13.9% | 15.4% | – | – | |
| 1.1% | 1.0% | 1.0% | 0.8% | 0.6% | 0.6% | 0.6% | – | – | 0.0% | 15.7% | 32.8% | |
| 1.1% | 1.0% | 1.0% | 0.8% | 0.6% | 0.6% | 0.6% | 0.5% | 0.5% | 3.4% | 6.6% | 13.3% | |
| 10.4% | 9.0% | 7.8% | 17.2% | 14.2% | 12.8% | 16.3% | 24.6% | 19.4% | 35.3% | 43.1% | 64.4% | |
| 10.3% | 9.0% | 7.8% | 16.3% | 13.4% | 12.1% | 15.7% | 24.0% | 18.8% | 33.8% | 42.5% | 64.1% | |
| – | – | – | – | – | – | – | – | – | – | 0.3% | 0.6% | |
| 7.4% | 6.2% | 5.5% | 13.5% | 11.3% | 10.5% | 12.7% | 21.1% | 15.6% | 14.8% | 21.8% | 25.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 89.6% | 91.0% | 92.2% | 82.8% | 85.8% | 87.2% | 83.7% | 75.4% | 80.6% | 64.7% | 56.9% | 35.6% | |
| 87.6% | 87.3% | 86.7% | 76.7% | 78.9% | 79.1% | 81.2% | 71.5% | 74.0% | 53.9% | 42.1% | 11.4% | |
| 25.6% | 24.3% | 22.4% | 18.1% | 15.2% | 13.3% | 12.9% | 10.7% | 11.5% | 12.0% | 12.0% | 25.8% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.